Xu-Hua Mao, [email protected] These authors share first authorship Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
A 2020 study among older adults in an exercise program experienced greater health benefits when taking L-glutamine supplements
Although the subsequent phase III trial with figitumumab as first-line treatment in NSCLC cancer was greatly anticipated, it was stopped early when interim analysis failed to show a benefit in the figitumumab arm [117]
Ahn CW, Kim CS, Nam JH, Kim HJ, Nam JS, Park JS, et al
Solid matrix-antibody-antigen complexes induce antigen-specific CD8+ cells that clear a persistent paramyxovirus infection